Gara Jalqabaatti › Baayyee Ulfaataa › North Carolina › Wilmington
Qorannoo klinikaalii Baayyee Ulfaataa Wilmington, NC keessatti
Qorannoo 11 Baayyee Ulfaataa f Wilmington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 2
- Accellacare - Tradd Court - Wilmington /ID# 282200, Wilmington
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Accellacare - Wilmington, Wilmington
- Jeffrey Coleman, OD, Wilmington
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Namoota walitti qabaa jiraSadarkaa 2
- TMA Headlands, Wilmington
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Namoota walitti qabaa jiraSadarkaa 3
- Accellacare and KDCILM, LLC, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Namoota walitti qabaa jiraSadarkaa 3
- Accellacare - Wilmington - 1917 Tradd Court, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Namoota walitti qabaa jiraSadarkaa 3
- KDCILM, LLC & Accellacare US, Inc., Wilmington
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Namoota walitti qabaa jiraSadarkaa 3
- Accellacare Research of Wilmington, Wilmington
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Namoota walitti qabaa jiraSadarkaa 3
- ACCOMPLISH-1 Research Site, Wilmington
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Namoota walitti qabaa jiraSadarkaa 1
- Accellacare, Wilmington
Qorannoo Baayyee Ulfaataa magaalota biroo keessatti
- San Antonio, TXQorannoo 34
- Houston, TXQorannoo 33
- Chicago, ILQorannoo 29
- Orlando, FLQorannoo 27
- Las Vegas, NVQorannoo 23
- Miami, FLQorannoo 23
- Dallas, TXQorannoo 20
- Atlanta, GAQorannoo 20
- New York City, NYQorannoo 19
- Jacksonville, FLQorannoo 19
- Washington, DCQorannoo 19
- Austin, TXQorannoo 18
Qorannoo biroo Wilmington keessatti
- ObesityQorannoo 15
- Sukkaraa Gosa 2Qorannoo 8
- Cufama OnneeQorannoo 6
- Colitis UlcerativeQorannoo 4
- KolestarooliiQorannoo 3
- Dhibee Onneessaa fi DhiigaQorannoo 3
- Dhiibbaa Dhiigaa Ol'aanaaQorannoo 3
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.